Farms.com Home   News

Leading businesses associations call on parliamentarians to pass CUSMA without further delay

Ottawa – With the conclusion of the House of Commons Standing Committee on International Trade’s study of Bill C-4, An Act implement the Agreement between Canada, the United States of America and the United Mexican States, a group of leading Canadian business associations called on all parliamentarians to pass the bill without further delay.
 
Given the numerous challenges facing the Canadian economy, now is the time to set aside short-term political interests for the national interest.
 
Thousands of Canadian businesses and millions of jobs depend on trade and investment with the United States, our most important trading partner. With the Unites States and Mexico already ratifying this important agreement, there should be nothing stopping Canada from ending the uncertainty and finally restoring long-term predictability to North American supply chains.
 
The message was delivered by the Business Council of Canada, the Canadian Agri-Food Trade Alliance, the Canadian Chamber of Commerce, the Canadian Federation of Independent Business, and Canadian Manufacturers & Exporters. Together, they represent companies of all sizes, in all regions of the country, from all sectors of the economy, and employing millions of Canadians.
Source : CAFTA

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.